Shandong Realcan Pharmaceutical Co Ltd (002589) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Shandong Realcan Pharmaceutical Co Ltd (002589) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.60 Million ≈ $-2.28 Million USD) by net assets (CN¥5.45 Billion ≈ $798.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Shandong Realcan Pharmaceutical Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Shandong Realcan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Shandong Realcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 002589 book value for net asset value and shareholders' equity analysis.

Shandong Realcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shandong Realcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
FERROGLOBE PLC DL 750 F:5FG	-0.008x
Energiekontor AG F:EKT	-0.007x
Washington Trust Bancorp Inc NASDAQ:WASH	0.041x
Yunnan Coal & Energy Co Ltd SHG:600792	0.091x
ChemPartner PharmaTech Co Ltd SHE:300149	0.022x
Bank Bukopin Tbk JK:BBKP	-0.331x
Harbin Dongan Auto Engine Co Ltd SHG:600178	0.033x
Hainan RuiZe New Building Material Co Ltd SHE:002596	-0.008x

Annual Cash Flow Conversion Efficiency for Shandong Realcan Pharmaceutical Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 002589 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.69 Billion ≈ $833.30 Million	CN¥160.44 Million ≈ $23.48 Million	0.028x	+92.59%
2023-12-31	CN¥5.64 Billion ≈ $824.87 Million	CN¥82.47 Million ≈ $12.07 Million	0.015x	-83.91%
2022-12-31	CN¥5.75 Billion ≈ $841.67 Million	CN¥523.07 Million ≈ $76.54 Million	0.091x	+99.01%
2021-12-31	CN¥9.69 Billion ≈ $1.42 Billion	CN¥442.95 Million ≈ $64.82 Million	0.046x	+6.19%
2020-12-31	CN¥9.64 Billion ≈ $1.41 Billion	CN¥414.96 Million ≈ $60.72 Million	0.043x	-78.93%
2019-12-31	CN¥10.25 Billion ≈ $1.50 Billion	CN¥2.09 Billion ≈ $306.49 Million	0.204x	+1245.34%
2018-12-31	CN¥11.31 Billion ≈ $1.65 Billion	CN¥-201.66 Million ≈ $-29.51 Million	-0.018x	+92.88%
2017-12-31	CN¥9.67 Billion ≈ $1.42 Billion	CN¥-2.42 Billion ≈ $-354.40 Million	-0.250x	-6.78%
2016-12-31	CN¥7.50 Billion ≈ $1.10 Billion	CN¥-1.76 Billion ≈ $-257.40 Million	-0.234x	-71.19%
2015-12-31	CN¥3.40 Billion ≈ $498.16 Million	CN¥-466.26 Million ≈ $-68.23 Million	-0.137x	-52.79%
2014-12-31	CN¥1.83 Billion ≈ $267.10 Million	CN¥-163.62 Million ≈ $-23.94 Million	-0.090x	+46.11%
2013-12-31	CN¥1.65 Billion ≈ $241.45 Million	CN¥-274.46 Million ≈ $-40.16 Million	-0.166x	+10.61%
2012-12-31	CN¥916.39 Million ≈ $134.10 Million	CN¥-170.52 Million ≈ $-24.95 Million	-0.186x	+67.99%
2011-12-31	CN¥817.11 Million ≈ $119.57 Million	CN¥-475.03 Million ≈ $-69.51 Million	-0.581x	-343.92%
2010-12-31	CN¥296.03 Million ≈ $43.32 Million	CN¥70.56 Million ≈ $10.32 Million	0.238x	-9.07%
2009-12-31	CN¥234.18 Million ≈ $34.27 Million	CN¥61.38 Million ≈ $8.98 Million	0.262x	+158.80%
2008-12-31	CN¥111.89 Million ≈ $16.37 Million	CN¥-49.88 Million ≈ $-7.30 Million	-0.446x	--

About Shandong Realcan Pharmaceutical Co Ltd

SHE:002589 China Medical Distribution

Market Cap

$616.52 Million

CN¥4.21 Billion CNY

Market Cap Rank

#11481 Global

#3358 in China

Share Price

CN¥2.80

Change (1 day)

-2.78%

52-Week Range

CN¥2.80 - CN¥4.69

All Time High

CN¥17.35